Thanks for the MST report it all makes perfect sense compounding revenue growth.
BTW it's looking very likely " finally " that MSB will get its remestemcel L FDA approved in the next 6 months for graft vs host disease which will lead to substantial revenue. Sometimes it pays to just show some patience and I am sure EYE will be hugely successful the writing is on the wall.
Nova Eye Medical (EYE) Discussion, page-2795
-
- There are more pages in this discussion • 393 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.91M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $73.06K | 304.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 342553 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 50108 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |